Related Experiment Video
Updated: Jun 14, 2026

06:46
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026
Single-port extraperitoneal right hemicolectomy with complete mesocolic -A human cadaveric study
Najam Husain1, Muhammad Abdalkoddus2, Alka M Jadav3
1University Hospitals of Derby and Burton NHS Trust, Derby, UK.
Summary
The EXPERTS approach for right hemicolectomy with complete mesocolic excision (CME) is anatomically feasible. This extraperitoneal technique allows for safe identification of critical structures, supporting further clinical evaluation.
Area of Science:
- Surgical Anatomy
- Minimally Invasive Surgery
- Oncologic Surgery
Background:
- Extraperitoneal access is established for left colectomies.
- Right-sided colectomy with complete mesocolic excision (CME) using this approach is not well-described.
- The EXPERTS (EXtraPEritoneal coloRecTal Surgery) with CME approach combines oncologic benefits of CME with extraperitoneal safety.
Purpose of the Study:
- To assess the anatomical feasibility, reproducibility, and visualization of critical structures for an extraperitoneal right hemicolectomy with CME.
- To evaluate the EXPERTS approach in accordance with the IDEAL framework (Stage 0).
Main Methods:
- A cadaveric study involving 11 dissections (9 Thiel-preserved, 2 fresh frozen).
- Assessment of anatomical feasibility, reproducibility, and visualization of key structures.
- Video recording and analysis of all dissections.
Main Results:
- Consistent identification of anatomical structures (kidney, duodenum, SMA, SMV) was achieved in 9 out of 11 cadavers via an extraperitoneal approach.
- Thiel-preserved cadavers offered better tissue quality and plane definition compared to fresh frozen.
- High-quality operative videos were obtained for analysis.
Conclusions:
- This IDEAL Stage 0 study confirms the anatomical feasibility of an extraperitoneal approach for right hemicolectomy with CME.
- The EXPERTS approach supports progression to clinical trials to evaluate safety and effectiveness.

